Xiaqiuyu, vice president of Tianjin Joint Institute of international biomedicine, and liuzhuyan, director of science and Technology Commission of Tianjin Binhai New AreaPharmaSep 2013Address at the opening ceremony of the conference,28The conference report was presided over by wangqunjie, general manager of Tianjin Bona ager Technology Co., Ltd., Dr. xifengde, deputy general manager of United States pharmaceuticals USP China, guohongzhu, deputy director of Beijing Institute for drug control, xiaobaiming, executive technical director of Jiangsu Xiansheng Pharmaceutical Co., Ltd., and other people made wonderful reports,29The conference report was chaired by Professor liuhuwei of Peking University. Zhang Yukui, academician of Chinese Academy of Sciences, zhaoyuqing, Dean of School of traditional Chinese medicine of Shenyang Pharmaceutical University, Lihua, researcher of Institute of toxicology and medicine of Academy of Military Medical Sciences, and other guests shared their rich experience.
28The branch report of the day is divided into4Topics
The wonderful report attracted many institutions to participate in the study and exchange. The participants included more than ten drug inspection and drug research units, including Beijing Institute for drug control, Dagang Institute for drug control, Tianjin Institute for drug control, Tianjin Institute of drug research, etc; HongRi pharmaceutical, Tianjin Tianshili holding group, Zhongxin pharmaceutical, Shanghai Xiansheng pharmaceutical, Wuxi apptec, kailaiying, Roche pharmaceutical, Shandong new era Pharmaceutical Co., Ltd Chengdu Biopurify Phytochemicals Ltd.， Huahai Pharmaceutical Co., Ltd30Several pharmaceutical enterprises andCROThe company; There are more than a dozen universities and scientific research institutions, including Nankai University, Tianjin University, Tianjin University of traditional Chinese medicine, Peking University, Beijing Industrial and Commercial University, Suzhou University, Guangxi Medical University, Shenyang Pharmaceutical University, etc.
